Drug cuts prostate cancer risk by thirty percent
Long term results from a major federal study show finasteride lowers prostate cancer risk by 30 percent without increasing death risk from aggressive disease. The finding may renew interest in using the drug for prevention, potentially reducing tens of thousands of cases yearly. Merck’s Proscar and generic finasteride, with lower dose Propecia, treat enlarged prostates and hair loss respectively.
MENTIONED IN THIS ARTICLE
Merck & Co
Half of small insurer buyers may get tax credits under health law
A Kaiser Family Foundation study finds about 48 percent of people who currently buy their own health plans could qualify for federal tax credits next year, averaging 5,548 dollars per family and covering 66 percent of a benchmark silver policy. Lower earners gain aid while higher earners pay more.
MENTIONED IN THIS ARTICLE
Washington, D.C
Barack Obama
Kaiser Family Foundation
Ally
Also Mentioned on This Page
Charles Dharapak
National Cancer Institute
Panl OE
Ee Mee
suYgren
GNLOE
Enloeresidential.com
Www
Kroger.com
Dancen
Kroger
QTV
Kroger Limited Partnership